{"id":"https://openalex.org/W2013808156","doi":"https://doi.org/10.1161/01.cir.87.5.1524","title":"Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.","display_name":"Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.","publication_year":1993,"publication_date":"1993-05-01","ids":{"openalex":"https://openalex.org/W2013808156","doi":"https://doi.org/10.1161/01.cir.87.5.1524","mag":"2013808156","pmid":"https://pubmed.ncbi.nlm.nih.gov/8491007"},"language":"en","primary_location":{"id":"doi:10.1161/01.cir.87.5.1524","doi":"https://doi.org/10.1161/01.cir.87.5.1524","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.87.5.1524","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"A Meijer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Meijer","raw_affiliation_strings":["Free University Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Free University Hospital, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065978967","display_name":"Freek W.A. Verheugt","orcid":"https://orcid.org/0000-0002-5831-6951","observed_orcids":["https://orcid.org/0000-0002-5831-6951","https://orcid.org/0000-0003-0373-0028"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F W Verheugt","raw_affiliation_strings":["Free University Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Free University Hospital, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059719551","display_name":"Christ J.P.J. Werter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C J Werter","raw_affiliation_strings":["Free University Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Free University Hospital, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109044744","display_name":"Kong Ing Lie","orcid":"https://orcid.org/0000-0002-5779-5989","observed_orcids":["https://orcid.org/0000-0002-5779-5989"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K I Lie","raw_affiliation_strings":["Free University Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Free University Hospital, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073503367","display_name":"Joop M.J. van der Pol","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J M van der Pol","raw_affiliation_strings":["Free University Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Free University Hospital, Amsterdam, The Netherlands","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048705133","display_name":"Machiel J. van Eenige","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J van Eenige","raw_affiliation_strings":["Free University Hospital, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Free University Hospital, Amsterdam, The Netherlands","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":15.308,"has_fulltext":false,"cited_by_count":203,"citation_normalized_percentile":{"value":0.99322151,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"87","issue":"5","first_page":"1524","last_page":"1530"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.8008000254631042,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.8008000254631042,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.17479999363422394,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10193","display_name":"Coronary Interventions and Diagnostics","score":0.009999999776482582,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/warfarin","display_name":"warfarin","score":0.902999997138977},{"id":"https://openalex.org/keywords/intravenous-thrombolysis","display_name":"intravenous thrombolysis","score":0.7480000257492065},{"id":"https://openalex.org/keywords/coronary-reocclusion","display_name":"coronary reocclusion","score":0.7900000214576721},{"id":"https://openalex.org/keywords/recurrent-myocardial-infarction","display_name":"reinfarction","score":0.8790000081062317},{"id":"https://openalex.org/keywords/antithrombotic-therapy","display_name":"antithrombotic therapy","score":0.8029999732971191},{"id":"https://openalex.org/keywords/heparin","display_name":"heparin","score":0.8939999938011169},{"id":"https://openalex.org/keywords/oral-anticoagulation","display_name":"oral anticoagulation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/revascularization","display_name":"revascularization","score":0.6389999985694885},{"id":"https://openalex.org/keywords/left-ventricular-ejection-fraction","display_name":"left ventricular ejection fraction","score":0.8930000066757202},{"id":"https://openalex.org/keywords/infarct-related-artery","display_name":"infarct-related artery","score":0.6819999814033508},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.7350000143051147},{"id":"https://openalex.org/keywords/ventricular-function-recovery","display_name":"ventricular function recovery","score":0.503000020980835},{"id":"https://openalex.org/keywords/coronary-angiography-follow-up","display_name":"coronary angiography follow-up","score":0.4749999940395355}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9536020755767822},{"id":"https://openalex.org/C2777628954","wikidata":"https://www.wikidata.org/wiki/Q18216","display_name":"Aspirin","level":2,"score":0.9082325100898743},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.825822114944458},{"id":"https://openalex.org/C2779581417","wikidata":"https://www.wikidata.org/wiki/Q1931577","display_name":"Thrombolysis","level":3,"score":0.6379029154777527},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5564287900924683},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.537494957447052},{"id":"https://openalex.org/C2778205648","wikidata":"https://www.wikidata.org/wiki/Q215118","display_name":"Anticoagulant","level":2,"score":0.4951280653476715},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.4493546485900879},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4190978407859802},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.4069303274154663},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35585469007492065},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.2733945846557617},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001241","descriptor_name":"Aspirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003328","descriptor_name":"Coronary Thrombosis","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":true},{"descriptor_ui":"D003328","descriptor_name":"Coronary Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003328","descriptor_name":"Coronary Thrombosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014859","descriptor_name":"Warfarin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017023","descriptor_name":"Coronary Angiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1161/01.cir.87.5.1524","doi":"https://doi.org/10.1161/01.cir.87.5.1524","is_oa":false,"landing_page_url":"https://doi.org/10.1161/01.cir.87.5.1524","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},{"id":"pmid:8491007","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8491007","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Clinical Trial"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.608.8286","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.608.8286","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://circ.ahajournals.org/content/87/5/1524.full.pdf","raw_type":"text"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/520fd064-f9f9-4fee-b40c-f69e263976c0","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/520fd064-f9f9-4fee-b40c-f69e263976c0","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"VERHEUGT, FWA, WERTER, CJPJ, LIE, KI, VANDERPOL, JMJ & VANEENIGE, MJ 1993, 'ASPIRIN VERSUS COUMADIN IN THE PREVENTION OF REOCCLUSION AND RECURRENT ISCHEMIA AFTER SUCCESSFUL THROMBOLYSIS - A PROSPECTIVE PLACEBO-CONTROLLED ANGIOGRAPHIC STUDY - RESULTS OF THE APRICOT STUDY', Circulation, vol. 87, no. 5, pp. 1524-1530.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/520fd064-f9f9-4fee-b40c-f69e263976c0","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/520fd064-f9f9-4fee-b40c-f69e263976c0","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Circulation, 87(5), 1524 - 1530. LIPPINCOTT WILLIAMS &amp; WILKINS","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W1983126671","https://openalex.org/W2164771213"],"related_works":["https://openalex.org/W7098220177","https://openalex.org/W7073855026","https://openalex.org/W2017371386","https://openalex.org/W4242265420","https://openalex.org/W2119020141","https://openalex.org/W2108862183","https://openalex.org/W2580301321","https://openalex.org/W2091767169","https://openalex.org/W2566710903","https://openalex.org/W4249028093"],"abstract_inverted_index":{"BACKGROUND:":[0],"Successful":[1],"coronary":[2],"thrombolysis":[3],"involves":[4],"a":[5,50],"risk":[6],"for":[7,333],"reocclusion":[8,235,279,328],"that":[9,323],"cannot":[10],"be":[11],"prevented":[12],"by":[13,44],"invasive":[14],"strategies.":[15],"Therefore,":[16],"we":[17],"studied":[18],"the":[19,26,265,288,331],"effects":[20],"of":[21,76,83,121,127,134,143,256,284,287,290,314,324],"three":[22],"antithrombotic":[23,335],"regimens":[24],"on":[25,145,149,154,316],"angiographic":[27],"and":[28,105,131,151,176,194,214,246,300,306],"clinical":[29,202],"courses":[30],"after":[31,276],"successful":[32,277],"thrombolysis.":[33],"METHODS":[34],"AND":[35],"RESULTS:":[36],"Patients":[37],"treated":[38],"with":[39,74,81,123,129,136,171,174,178,208,212,217,240,244,249,293],"intravenous":[40,45],"thrombolytic":[41],"therapy":[42,336],"followed":[43],"heparin":[46,77,84],"were":[47,64,108,115],"eligible":[48],"when":[49],"patent":[51],"infarct-related":[52],"artery":[53],"was":[54,88,101,139,169,192,204,236,261],"demonstrated":[55],"at":[56],"angiography":[57],"<":[58,160,184,223,229,270],"48":[59],"hours.":[60],"Three":[61],"hundred":[62],"patients":[63,144],"randomized":[65],"to":[66,79],"either":[67],"325":[68],"mg":[69],"aspirin":[70,225,266,295],"daily":[71],"or":[72,78],"placebo":[73,155,179,218,250],"discontinuation":[75],"Coumadin":[80,315],"continuation":[82],"until":[85],"oral":[86],"anticoagulation":[87],"established":[89],"(international":[90],"normalized":[91],"ratio,":[92],"2.8-4.0).":[93],"After":[94],"3":[95,274],"months,":[96],"in":[97,110,141,147,152,206,210,215,238,242,247,264,281,337],"which":[98],"conservative":[99],"treatment":[100],"intended,":[102],"vessel":[103],"patency":[104],"ventricular":[106,258,310],"function":[107],"reassessed":[109],"248":[111],"patients.":[112,339],"Reocclusion":[113],"rates":[114],"not":[116,196],"significantly":[117,296],"different:":[118],"25%":[119],"(23":[120],"93)":[122],"aspirin,":[124,146,172,209,241],"30%":[125,283],"(24":[126,133],"81)":[128],"Coumadin,":[130,150,175,213,227,245],"32%":[132],"74)":[135],"placebo.":[137],"Reinfarction":[138],"seen":[140,205],"3%":[142],"8%":[148],"11%":[153],"(aspirin":[156,180,219],"versus":[157,181,220,226],"placebo,":[158,182,221,294],"p":[159,164,183,188,222,228,269],"0.025;":[161],"other":[162,186],"comparison,":[163],"=":[165,189,252],"NS).":[166,190,253],"Revascularization":[167],"rate":[168,299,329],"6%":[170],"13%":[173],"16%":[177],"0.05;":[185],"comparisons,":[187],"Mortality":[191],"2%":[193],"did":[195],"differ":[197],"between":[198],"groups.":[199],"An":[200,231,254],"event-free":[201,232,304],"course":[203,233],"93%":[207],"82%":[211],"76%":[216],"0.001;":[224],"0.05).":[230],"without":[234],"observed":[237],"73%":[239],"63%":[243],"59%":[248],"(p":[251],"increase":[255],"left":[257,309],"ejection":[259],"fraction":[260],"only":[262],"found":[263],"group":[267],"(4.6%,":[268],"0.001).":[271],"CONCLUSIONS:":[272],"At":[273],"months":[275],"thrombolysis,":[278],"occurred":[280],"about":[282],"patients,":[285],"regardless":[286],"use":[289],"antithrombotics.":[291],"Compared":[292],"reduces":[297],"reinfarction":[298],"revascularization":[301],"rate,":[302],"improves":[303],"survival,":[305],"better":[307,334],"preserves":[308],"function.":[311],"The":[312,326],"efficacy":[313],"these":[317,338],"end":[318],"points":[319],"appears":[320],"less":[321],"than":[322],"aspirin.":[325],"still-high":[327],"emphasizes":[330],"need":[332]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}